Stressing on continued vigilance and high state of preparedness against the pandemic, the PM told a review meeting that the facility to get tested regularly, speedily and inexpensively must be available to all at the earliest. He also underscored the need for continuous and rigorous scientific testing and validation of traditional medicine treatments.
The PM took stock of the health ministry’s comprehensive distribution and delivery mechanism for the vaccines including for adequate procurement, and technologies for bulk-stockpiling, filling vials for distribution and ensuring effective delivery.
The meeting was attended by Union health minister Harsh Vardhan, NITI Aayog member for health Dr V K Paul, the principal scientific advisor, senior scientists, and other top officials.
The PM lauded the efforts made by Indian vaccine developers and manufacturers to rise to the Covid-19 challenge, and committed to continue government facilitation and support for all such efforts.
He also stated that regulatory reform was a dynamic process, and experts in every current and emerging domain should be used by the regulator pro-actively, as many new approaches have emerged.
He appreciated the efforts of the AYUSH ministry for conducting evidence-based research and providing reliable solutions in this difficult time.
The Prime Minister reiterated India’s resolve to provide cost effective, easily available and scalable solutions for testing, vaccine and medication, not only for the country but for the entire world.
Meanwhile, India’s active Covid-19 cases continued to edge lower as recoveries outpaced the increase in fresh infections. On Wednesday, there were 8.12 lakh active Covid cases in the country after 67,708 new cases were reported in a span of 24 hours. Overall case tally now stands at 73.07 lakh, which includes 63.83 lakh cured and 1.11 lakh fatalities.